Impaired blood rheology and elevated remnant-like lipoprotein particle cholesterol in hypercholesterolaemic subjects

Journal of International Medical Research

Volumn 37, Issue 2, 2009, Pages 308-317

  Nara, M ^a   Sumino, H ^b   Machida, T ^a   Amagai, H ^a   Nakajima, K ^c   Murakami, Masami ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Blood flow; Dyslipidaemia; Lipoproteins

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REMNANT LIKE LIPOPROTEIN PARTICLE CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; LIPID; LIPOPROTEIN; REMNANT LIKE PARTICLE CHOLESTEROL; REMNANT-LIKE PARTICLE CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD RHEOLOGY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE DEFORMABILITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; BLOOD; ERYTHROCYTE; FLOW KINETICS; HEMATOCRIT; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

ADULT; CHOLESTEROL; ERYTHROCYTES; FEMALE; HEMATOCRIT; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; RHEOLOGY; TIME FACTORS; TRIGLYCERIDES;

EID: 66649099120     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700204     Document Type: Article

References (35)

1. Martin MJ, Hulley SB, Browner WS, et a: Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 1982; ii: 933-936.
2. Philips NR, Waters D, Havel RJ: Plasma lipoproteins and progression of coronary artery disease evaluated by angiogrhapy and clinical events. Circulation 1993; 88: 2762-2770.
3. Zilversmit DB: Atherogenic nature of triglycerides, postprandial lipemia, and triglyceride-rich remnant lipoproteins. Clin Chem 1995; 41: 153-158.
4. Nakajima K, Saito T, Tamura A, et al: Cholesterol in remnant like lipoproteins in human serum using monoclonal anti-apo B-100 and anti-apo A-I immunoaffinity mixed gels. Clin Chim Acta 1993; 23: 53-71.
5. McNamara JR, Shah PK, Nakajima K, et al: Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study. Clin Chem 1998; 44: 1224-1232.
6. Ernst E, Resch KL: Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993; 118: 956-963.
7. Danesh J, Collins R, Appleby P, et al: Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analysis of prospective studies. JAMA 1998; 279: 1477-1482.
8. Yarnell JW, Baker IA, Sweetnam PM, et al: Fibrinogen, viscosity and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991;83:836-844.
9. Koenig W, Sund M, Filipiak B, et al: Plasma viscosity and the risk of coronary heart disease. Results from the MONICA-Augsburg Cohort Study, 1984 to 1992. Arterioscler Thromb Vasc Biol 1998; 18: 768-772.
10. Lowe GD, Lee AJ, Rumley Aw, et al: Blood viscosity and risk of cardioviovascular events: the Edinburgh Artery Study. Br J Haematol 1997; 96: 168-173.
11. Lee AJ, Mowbray PI, Lowe GD, et al: Blood viscosity and elevated carotid intima-media thickness in men and women. The Edinburgh Artery Study. Circulation 1998; 97: 1467-1473.
12. Koenig W, Sund M, Ernst E, et al: Association between rheology and components of lipoproteins in human blood: results from the MONICA Project Augsburg. Circulation 1992; 85: 2197-2204.
13. Lowe GD, Wood DA, Douglas JT, et al: Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thromb Haemost 1991; 65: 339-343.
14. Surya II, Akkerman JW: The influence of lipoproteins on blood platelets. Am Heart J 1993; 125: 272-275.
15. Kurihara T, Deguchi S, Kato J, et al: Impaired blood rheology by remnant-like lipoprotein particles: studies in patients with fatty liver disease. Clin Hemorheol Microcirc 2001; 24: 217-225.
16. Kikuchi Y, Sato K, Ohki H, et al: Optically accessible microchannels formed in a single-crystal silicon substrate for studies of blood rheology. Microvasc Res 1992; 44: 226-240.
17. Seki K, Sumino H, Nara M, et al: Relationships between blood rheology and age, body mass index, blood cell count, firinogen, and lipids in healhty subjects. Clin Hemorheol Microcirc 2006; 34: 401-410.
18. Sumino H, Nara M, Seki K, et al: Effect of antihypertensive therapy on blood rheology in patients with essential hypertension. J Int Med Res 2005; 33: 170-177.
19. Sumino H, Ichikawa S, Takahashi T, et al: Conjugated estrogen plus medroxyprogesterone does not impair blood rheolgical properties in hypertensive postmenopausal women. Maturitas 2005; 53: 306-314.
20. Muranaka Y, Kunimoto F, Takita J, et al: Impaired blood rheology in critically ill patients in intensive care unit. J Int Med Res 2006; 34: 419-427.
21. Tsukada K, Sekizuka E, Oshio C, et al: Direct measurement of erythrocyte deformability in diabetes mellitus with a transparent microchannel capillary model and high-speed video camera system. Microvasc Res 2001; 61: 231-239.
22. Japanese Atherosclerosis Society: Investigating Committee of Guidelines for Diagnosis and Treatment of Hyperlipidemias. J Jpn Atheroscler Soc 1997; 25: 1-34.
23. Lee CYJ, Kim KC, Park HW, et al: Rheological properties of erythrocytes from male hypercholesterolemia. Microvasc Res 2004; 67: 133-138.
24. Rosenson RS, Lowe GD: Effecsts of lipids and lipoproteins on thrombosis and rheology. Atherosclerosis 1998; 140: 271-280.
25. Kanakaraji P, Singh M: Influence of hypercholesterolemia on morphological and rheological charactetistics of erythrocytes. Atherosclerosis 1989; 76: 209-218.
26. Chabanel A, Flamm M, Sung KL, et al: Influence of cholesterol content on red cell membrane viscoelasticity and fluidity. Biophys J 1983; 44: 171-176.
27. Seplowitz AH, Chien S, Smith EF: Effects of lipoproteins on plasma viscosity. Atherosclerosis 1981; 38: 88-95.
28. Leonhardt H, Arntz HR, Klemens UH: Studies of plasma viscosity in primary hyperlipoproteinemia. Atherosclerosis 1977; 28: 29-40.
29. Epand RM, Stafford A, Leon B, et al: HDL and apolipoprotein A-1 protect erythrocytes against the generation of procoagulant activity. Arterioscler Thromb 1994; 14: 1775-1783.
30. Cicha I, Suzuki Y, Tateishi N, et al: Effects of dietary triglycerides on rheological properties of human red blood cells. Clin Hemorheol Microcirc 2004; 30: 301-305 [abstract].
31. Rosenson RS, Shott S, Lu L, et al: Hypertriglyceridemia and other factors associated with plasma viscosity. Am J Med 2001; 110: 488-492.
32. Conteras T, Vayá A, Palanca S, et al: Influence of plasmatic lipids on the hemorheological profile in healthy adults. Clin Hemorheol Microcirc 2004; 30: 423-425.
33. Dane-Stewart CA, Watts GF, Mamo CJL, et al: Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolemia. Eur J Cin Invest 2001; 31: 113-117.
34. Saniabadi AR, Umemura K, Shimoyama M, et al: Aggregation of human blood platelets by remnant-likew lipoprotein particles of plasma chylomicrons and very low density lipoproteins. Thromb Haemost 1997; 77: 996-1001.
35. Saniabadi AR, Umemura K, Suzuki Y, et al: Adenosine 5′-diphoshate as a factor in platelet aggregation induced by human plasma remnant lipoproteins. Life Sci 1998; 63: 1065-1074.